Table 1.
Number of studies and sample sizes by treatment and study characteristics
# studies | N | # studies | N | # studies | N | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Settinga | Outpatient | Day-treatment | Inpatient | |||||||||
83 | 4938 | 15 | 1158 | 17 | 3004 | |||||||
Formata | Individual + Group | Individual | Group | |||||||||
74 | 6595 | 43 | 1652 | 13 | 853 | |||||||
Study design | Open Trial | RCT | Non-randomized controlled | |||||||||
58 | 5008 | 44 | 3397 | 9 | 695 | |||||||
Add-on to TAUa | Not added to TAU | Added to TAU | ||||||||||
110 | 8853 | 7 | 247 | |||||||||
Medication | Not prescribed | Prescribed | ||||||||||
106 | 8946 | 5 | 154 | |||||||||
Dropout type | Treatment dropout distinguished from Study dropout | Study and treatment dropout not distinguished | ||||||||||
90 | 7775 | 21 | 1325 | |||||||||
Dropout per Quarterb | Completely reported | Partially reported | Not reported | |||||||||
87 | 7232 | 7 | 483 | 20 | 1385 | |||||||
Country group | Europe | USA | Australia/Canada/NewZealand | Emerging | ||||||||
48 | 4781 | 27 | 1089 | 6 | 418 | 418 | 341 |
Note that some studies investigated multiple settings/formats/models. Hence, #studies >111 in these rows.
Note that some studies had complete dropout reports for one arm, but not or partially reported for another arm. Hence, #studies >111 in this row.